Today: 21 May 2026
Browse Category

TSX:CLS 27 October 2025 - 19 May 2026

Celestica Drops in Toronto as AI Hardware Trade Struggles

Celestica Drops in Toronto as AI Hardware Trade Struggles

Celestica’s Toronto-listed shares fell about 5% Tuesday as the TSX reopened after Victoria Day, mirroring a 4.4% drop in its U.S.-listed shares Monday. The stock has retreated despite Celestica raising its 2026 revenue and profit outlook last month. Shares traded near $340.54 in New York early Tuesday afternoon. Other contract manufacturers, including Jabil and Flex, also declined.
19 May 2026
··
Celestica Inc Stock (CLS) News Today: Why Shares Slid, What Analysts Forecast, and What to Watch Next

Celestica Inc Stock (CLS) News Today: Why Shares Slid, What Analysts Forecast, and What to Watch Next

Celestica shares fell 12.78% to $306.50 on December 12 amid a broader tech selloff linked to concerns over AI valuations and rising borrowing costs. The stock rebounded in early pre-market trading December 15, indicated at $312.10. B. Riley Wealth Advisors disclosed a new stake of 11,319 shares, while director Laurette T. Koellner bought 6,000 shares in October. Institutional investors hold about 67% of Celestica shares.
15 December 2025
·
Celestica Inc. Stock (CLS) Update: Why Shares Slumped, What Analysts Forecast, and the 2026 Outlook (Dec. 14, 2025)

Celestica Inc. Stock (CLS) Update: Why Shares Slumped, What Analysts Forecast, and the 2026 Outlook (Dec. 14, 2025)

Celestica shares fell nearly 13% Friday, closing at $306.50 on the NYSE and C$421.77 on the TSX, after a broad tech selloff and renewed “AI bubble” concerns. New institutional filings Sunday showed both buying and trimming of positions. Management reaffirmed a $16 billion revenue target and $8.20 adjusted EPS for 2026. RBC and Goldman maintained bullish price targets at $400 and $440, respectively.
14 December 2025
··
Celestica (CLS) Stock: Latest News, AI Data Center Outlook and Analyst Targets as of December 3, 2025

Celestica (CLS) Stock: Latest News, AI Data Center Outlook and Analyst Targets as of December 3, 2025

Celestica shares closed at $304.29 on December 2, down 4.4% but still up about 270% in 2025. The stock trades 16% below its $363 high, with a $35 billion market cap and trailing P/E near 49. Technical services flag near-term volatility after a steep run, but models still project possible gains if the uptrend holds. Celestica’s AI-driven growth has drawn increased attention from investors and analysts.
3 December 2025
···
Celestica Stock Skyrockets on AI Boom: Q3 Blowout, Raised Forecasts Signal No Slowdown

Celestica Stock Skyrockets on AI Boom: Q3 Blowout, Raised Forecasts Signal No Slowdown

Celestica shares closed at C$424 on Oct. 27, up 13% for the week and over 300% in a year. The company reported Q3 revenue of $3.19 billion, up 28%, and adjusted EPS of $1.58, up 52%, both above guidance. Celestica raised its 2025 outlook and now expects 2026 revenue to reach $16 billion amid strong AI hardware demand. Analysts raised price targets, citing robust orders from hyperscale customers.
27 October 2025
···

Stock Market Today

  • Stocks Climb as Oil Prices and Treasury Yields Drop Ahead of Nvidia Earnings
    May 20, 2026, 6:04 PM EDT. U.S. stocks surged with the Dow Jones up 1.31%, S&P 500 gaining 1.08%, and Nasdaq rising 1.54% on May 20, 2026. This followed a sharp decline in oil prices, with WTI crude down 5.66% at $98.26 per barrel, and Brent crude falling 5.63%. Lower oil prices came after reports of progress in Middle East peace talks. Treasury yields eased, with the 10-year yield dropping over 9 basis points, alleviating recent inflation concerns. Market focus shifts to Nvidia's Q1 earnings report, seen as a critical indicator for the AI sector and chip demand. Nvidia shares rose over 1% ahead of results, trading near a 20% gain for the year. Analysts caution that while expectations are muted, the report could influence the broader market sentiment significantly.

Latest articles

Xanadu Jumps 20% After Quantum Selloff, Filing Remains Over XNDU

Xanadu Jumps 20% After Quantum Selloff, Filing Remains Over XNDU

20 May 2026
Xanadu Quantum Technologies’ shares surged 20.4% to $14.13 Wednesday, rebounding after a sharp May decline. The company reported Q1 revenue of $2.83 million and a net loss of $20.6 million, with 43.3 million Class B shares outstanding and a prospectus covering up to 293.7 million more. Other quantum stocks also rose. Xanadu is in talks for up to $285 million in Canadian government support.
MicroAlgo Shares Surge 40% as Quantum Release Drives MLGO Spike

MicroAlgo Shares Surge 40% as Quantum Release Drives MLGO Spike

20 May 2026
MicroAlgo shares surged 39.95% to $5.36 after the company announced a quantum image-processing algorithm, with volume reaching 9.74 million shares versus a 447,270 average. The stock hit $6.87 intraday before slipping to $5.22 after hours. No customer deals, revenue targets, or product launch dates were disclosed. Market cap stood near $66.7 million at the close.
Immunovant Stock Surges 35% After Arthritis Drug Data: Why Wall Street Is Repricing IMVT

Immunovant Stock Surges 35% After Arthritis Drug Data: Why Wall Street Is Repricing IMVT

20 May 2026
Immunovant shares jumped 35.3% to $35.56 after reporting 16-week data showing its drug IMVT-1402 produced ACR20, ACR50, and ACR70 response rates of 72.7%, 54.5%, and 35.8% in difficult-to-treat rheumatoid arthritis. Roivant Sciences, its majority owner, rose 14.9%. No new safety signals were reported. The trial enrolled 170 patients, most of whom had failed two prior advanced therapies.
Go toTop